TakeJournal icon
TakeJournal icon

TakeJournal

A trading journal that builds one trade across every account your copier copied it to, and checks each account against its prop firm's rules.

The dashboard: equity, the day's result, each account's state and the latest trades.

Cost / License

  • Freemium (Subscription)
  • Proprietary

Platforms

  • Online
  • Software as a Service (SaaS)
0likes
0articles
Save

Features

Highlights All activities

TakeJournal News & Activities

Recent activities

TakeJournal information

  • Developed by

    CZ flagTakeJournal
  • Licensing

    Proprietary and Freemium product.
  • Pricing

    Subscription ranging between $29 and $99 per month + free version with limited functionality.
  • Alternatives

    50 alternatives listed
  • Badge

    Get an embeddable badge for TakeJournal
  • Supported Languages

    • English
    • Spanish
    • Portuguese
    • German
    • French

AlternativeTo Category

Business & Commerce
TakeJournal was added to AlternativeTo by jsedlak on and this page was last updated .

No comments or reviews, maybe you want to be first?

What is TakeJournal?

TakeJournal is a trading journal for futures, prop-firm and copy traders. It reads your fills from your broker or prop firm and builds your trades from them – one trade across every account a copier copied it to, instead of the same trade twenty times. Each account is checked against its firm's rules: the drawdown and how it trails, the daily loss limit, payouts. The copier itself is checked too: missed and late fills, the size each account took.

It syncs TopstepX, NinjaTrader 8 (add-on), MetaTrader 4/5, cTrader, TradeLocker, DXtrade, Match-Trader, IG, Capital.com, OANDA, Interactive Brokers and 22 crypto exchanges, imports Tradovate, NinjaTrader and other exports, and reads any broker's statement with an AI import. Calendar, statistics, strategies, a day journal and an optional AI review of the week. It only reads – it never places an order.

A free plan for one account, paid plans from $29 a month, and a 7-day trial of the full journal. A read-only demo on sample data needs no sign-up.